Jammu, India

Jaideep Bharate

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019.


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jaideep Bharate: Innovator in P-Glycoprotein Induction

Introduction

Jaideep Bharate is a notable inventor based in Jammu, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that induce P-glycoprotein. His work is crucial for advancing treatments for various diseases, including Alzheimer's.

Latest Patents

Jaideep Bharate holds a patent for "Polyprenylated phloroglucinol compounds as potent P-glycoprotein inducers." This invention relates to polyprenylated phloroglucinol compounds of specific formulae. The patent also details the synthesis and P-glycoprotein induction activity of alkyl- and acyl-polyprenylated phloroglucinol compounds. Furthermore, it discusses the use of these compounds as P-glycoprotein inducers and their potential application in treating Alzheimer's disease.

Career Highlights

Jaideep Bharate is affiliated with the Council of Scientific and Industrial Research, where he conducts research and development in the field of medicinal compounds. His innovative work has led to advancements in understanding how certain compounds can enhance drug absorption and efficacy.

Collaborations

Jaideep has collaborated with notable colleagues, including Sandip Bibishan Bharate and Ajay Kumar. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Jaideep Bharate's contributions to the field of medicinal chemistry, particularly through his patent on P-glycoprotein inducers, highlight his role as an innovator. His work not only advances scientific knowledge but also holds promise for improving treatment options for Alzheimer's disease.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…